John Staer - Transdigm Group Independent Director
| TDG Stock | USD 1,240 52.98 4.10% |
Director
Mr. John Staer is Independent Director of the company. Mr. Staer was formerly a director of Dalhoff Larsen Horneman AS, a Danish public company that is supplier of timber and wood products . He was formerly a director of Ambu AS, a Danish public company that is a manufacturer of hospital and rescue service equipment . He is Retired Chief Executive Officer of Satair AS, a subsidiary of Airbus, and a distributor of aerospace products, including parts manufactured by subsidiaries of the Company . Through 2013, Mr. Staer was CEO of Satair AS when it was a public company in Denmark and then as a subsidiary of Airbus. Satair is a distributor of aerospace products, including parts manufactured by subsidiaries of the Company. In addition, Mr. Staer has prior experience as a CFO since 2012.
| Age | 69 |
| Tenure | 12 years |
| Address | 1301 East 9th Street, Cleveland, OH, United States, 44115 |
| Phone | 216 706 2960 |
| Web | https://www.transdigm.com |
Transdigm Group Management Efficiency
The company has Return on Asset of 0.0981 % which means that on every $100 spent on assets, it made $0.0981 of profit. This is way below average. Transdigm Group's management efficiency ratios could be used to measure how well Transdigm Group manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.13. The current Return On Capital Employed is estimated to decrease to 0.1. At this time, Transdigm Group's Non Current Assets Total are most likely to increase significantly in the upcoming years. The Transdigm Group's current Non Currrent Assets Other is estimated to increase to about 8.4 B, while Other Current Assets are forecasted to increase to (5.5 B).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Steve Reid | Gold Fields Ltd | 63 | |
| BCompt BCom | Gold Fields Ltd | 57 | |
| Peter Wendell | Merck Company | 70 | |
| Marcia Backus | Western Midstream Partners | 64 | |
| Inge Thulin | Merck Company | 67 | |
| Thomas Glocer | Merck Company | 61 | |
| Leslie Brun | Merck Company | 68 | |
| Daniel IV | Western Midstream Partners | N/A | |
| Patricia Russo | Merck Company | 68 | |
| Kathy Warden | Merck Company | 49 | |
| Thomas Cech | Merck Company | 72 | |
| Lisa Stewart | Western Midstream Partners | 63 | |
| Jennifer Kirk | Western Midstream Partners | 44 | |
| Paul Rothman | Merck Company | 63 | |
| Peter Bennett | Western Midstream Partners | 52 | |
| Zane Karimi | Knife River | N/A | |
| David Tudor | Western Midstream Partners | 59 | |
| Pamela Craig | Merck Company | 64 | |
| Craig Stewart | Western Midstream Partners | 64 | |
| Thomas Hix | Western Midstream Partners | 71 | |
| Carmen Letton | Gold Fields Ltd | 54 | |
Management Performance
| Return On Asset | 0.0981 |
Transdigm Group Leadership Team
Elected by the shareholders, the Transdigm Group's board of directors comprises two types of representatives: Transdigm Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Transdigm. The board's role is to monitor Transdigm Group's management team and ensure that shareholders' interests are well served. Transdigm Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Transdigm Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bernt Iversen, Executive Vice President - Business Development and Mergers & Acquisitions | ||
| Patrick Murphy, Executive President | ||
| Michele Santana, Independent Director | ||
| Sarah Wynne, Chief Accounting Officer | ||
| Halle Terrion, Chief Compliance Officer, General Counsel, Secretary | ||
| Halle Martin, Chief Compliance Officer, General Counsel, Secretary | ||
| Jorge III, Chief Officer | ||
| John Staer, Independent Director | ||
| Paula Wheeler, Executive President | ||
| Michael Lisman, Chief Financial Officer | ||
| Jessica Warren, Chief Counsel | ||
| Robert Small, Independent Director | ||
| Robert Henderson, COO of Airframe | ||
| Kevin Stein, President, Chief Executive Officer, Director | ||
| David Barr, Independent Director | ||
| Mervin Dunn, Independent Director | ||
| Sean Hennessy, Independent Director | ||
| Jane Cronin, Independent Director | ||
| Raymond Laubenthal, Independent Director | ||
| Kevin McHenry, Executive President | ||
| Marko Enderlein, Executive President | ||
| Jorge Valladares, Executive Vice President and Chief Operating Officer of wer & Control Segment | ||
| W Howley, Non-Executive Chairman of the Board | ||
| Michael Hargas, President Products | ||
| Peter Palmer, Executive Vice President | ||
| Joel Reiss, Executive Vice President | ||
| Liza Sabol, Investor Relations | ||
| Michael Graff, Independent Director | ||
| Alex Feil, Executive President | ||
| Rodrigo Rubiano, Executive President | ||
| Gary McCullough, Independent Director |
Transdigm Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Transdigm Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.0981 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.43 % | ||||
| Current Valuation | 91.35 B | ||||
| Shares Outstanding | 56.23 M | ||||
| Shares Owned By Insiders | 0.40 % | ||||
| Shares Owned By Institutions | 94.91 % | ||||
| Number Of Shares Shorted | 889 K | ||||
| Price To Earning | 92.83 X | ||||
| Price To Sales | 9.16 X |
Currently Active Assets on Macroaxis
When determining whether Transdigm Group is a strong investment it is important to analyze Transdigm Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Transdigm Group's future performance. For an informed investment choice regarding Transdigm Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Transdigm Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Aerospace & Defense space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Transdigm Group. If investors know Transdigm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Transdigm Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.20) | Earnings Share 25.6 | Revenue Per Share 137.37 | Quarterly Revenue Growth 0.18 | Return On Assets 0.0981 |
The market value of Transdigm Group is measured differently than its book value, which is the value of Transdigm that is recorded on the company's balance sheet. Investors also form their own opinion of Transdigm Group's value that differs from its market value or its book value, called intrinsic value, which is Transdigm Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Transdigm Group's market value can be influenced by many factors that don't directly affect Transdigm Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Transdigm Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Transdigm Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Transdigm Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.